Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Capitalizing on value: 3 undervalued stocks ready for resurgence: https://www.marketbeat.com/logos/articles/med_20231113141556_capitalizing-on-value-3-undervalued-stocks-ready-f.jpg
Capitalizing on value: 3 undervalued stocks ready for resurgence

When it comes down to it, all investing and trading is about nothing more than buying low and selling high. Ideally, you want to find stocks with as much upside as possible and just ride the wave

2 stocks that missed earnings but surged higher: https://www.marketbeat.com/logos/articles/med_20231113081705_2-stocks-that-missed-earnings-but-surged-higher.jpg
2 stocks that missed earnings but surged higher

The stock market is not always right or rational, or is it just early? It makes investors scratch their heads when a company reports earnings that miss analyst expectations, but the stock goes

Bargain alert: 3 large caps with RSIs that scream oversold: https://www.marketbeat.com/logos/articles/med_20231113184324_bargain-alert-3-large-caps-with-rsis-that-scream-o.jpg
Bargain alert: 3 large caps with RSIs that scream oversold

Everyone likes to feel like they're getting a bargain when buying something. It's no different when it comes to buying stocks. One of the most widely used technical tools for assessing a stock's

Gen Digital is a leading consumer cyber safety stock to consider: https://www.marketbeat.com/logos/articles/med_20231112142308_chart-gen.jpg
Gen Digital is a leading consumer cyber safety stock to consider

Cybersecurity products and services provider Gen Digital Inc. (NASDAQ: GEN) may not sound familiar until you discover its products and brands. While enterprise cybersecurity firms like Palo Alto

4 high yields near 52-week lows worth looking at: https://www.marketbeat.com/logos/articles/med_20231113110019_chart-wba-11132023ver001.png
4 high yields near 52-week lows worth looking at

Marketbeat's stock screening tools are a wealth of investment ideas, including the 52-week low list. Stocks trading at 52-week lows often provide oversold value ready to spring back, given the

4 high yields near 52-week lows worth looking at: https://www.marketbeat.com/logos/articles/med_20231113110019_chart-wba-11132023ver001.png
4 high yields near 52-week lows worth looking at

Marketbeat's stock screening tools are a wealth of investment ideas, including the 52-week low list. Stocks trading at 52-week lows often provide oversold value ready to spring back, given the

Catch the dip on Sociedad Quimica before earnings?: https://www.marketbeat.com/logos/articles/med_20231113100938_catch-the-dip-on-sociedad-quimica-before-earnings.jpg
Catch the dip on Sociedad Quimica before earnings?

There is a power shift in the mining sector, and tons of variables are up in the air for grabs between the world's two economic powerhouses, the United States and China. When mining lithium and

Can new GPT store spur generative AI monetization?: https://www.marketbeat.com/logos/articles/med_20231113072753_can-new-gpt-store-spur-generative-ai-monetization.jpg
Can new GPT store spur generative AI monetization?

It’s no big deal to visit the Apple Inc. (NASDAQ: AAPL) app store, Alphabet Inc.’s (NASDAQ: GOOGL) Google Play or Microsoft Corp.’s (NASDAQ: MSFT) store. 

ChatGPT operator OpenAI, of which

Can new GPT store spur generative AI monetization?: https://www.marketbeat.com/logos/articles/med_20231113072753_can-new-gpt-store-spur-generative-ai-monetization.jpg
Can new GPT store spur generative AI monetization?

It’s no big deal to visit the Apple Inc. (NASDAQ: AAPL) app store, Alphabet Inc.’s (NASDAQ: GOOGL) Google Play or Microsoft Corp.’s (NASDAQ: MSFT) store. 

ChatGPT operator OpenAI, of which

Can new GPT store spur generative AI monetization?: https://www.marketbeat.com/logos/articles/med_20231113072753_can-new-gpt-store-spur-generative-ai-monetization.jpg
Can new GPT store spur generative AI monetization?

It’s no big deal to visit the Apple Inc. (NASDAQ: AAPL) app store, Alphabet Inc.’s (NASDAQ: GOOGL) Google Play or Microsoft Corp.’s (NASDAQ: MSFT) store. 

ChatGPT operator OpenAI, of which

Can new GPT store spur generative AI monetization?: https://www.marketbeat.com/logos/articles/med_20231113072753_can-new-gpt-store-spur-generative-ai-monetization.jpg
Can new GPT store spur generative AI monetization?

It’s no big deal to visit the Apple Inc. (NASDAQ: AAPL) app store, Alphabet Inc.’s (NASDAQ: GOOGL) Google Play or Microsoft Corp.’s (NASDAQ: MSFT) store. 

ChatGPT operator OpenAI, of which

Microsoft hits record highs as market impact strengthens: https://www.marketbeat.com/logos/articles/med_20231113063920_qqq.jpg
Microsoft hits record highs as market impact strengthens

Microsoft (NASDAQ: MSFT), the blue-chip tech juggernaut, recently hit an all-time high when the stock hit $370.10 on Friday. With a market capitalization soaring to an impressive $2.75 trillion

Microsoft hits record highs as market impact strengthens: https://www.marketbeat.com/logos/articles/med_20231113063920_qqq.jpg
Microsoft hits record highs as market impact strengthens

Microsoft (NASDAQ: MSFT), the blue-chip tech juggernaut, recently hit an all-time high when the stock hit $370.10 on Friday. With a market capitalization soaring to an impressive $2.75 trillion

Microsoft hits record highs as market impact strengthens: https://www.marketbeat.com/logos/articles/med_20231113063920_qqq.jpg
Microsoft hits record highs as market impact strengthens

Microsoft (NASDAQ: MSFT), the blue-chip tech juggernaut, recently hit an all-time high when the stock hit $370.10 on Friday. With a market capitalization soaring to an impressive $2.75 trillion

Microsoft hits record highs as market impact strengthens: https://www.marketbeat.com/logos/articles/med_20231113063920_qqq.jpg
Microsoft hits record highs as market impact strengthens

Microsoft (NASDAQ: MSFT), the blue-chip tech juggernaut, recently hit an all-time high when the stock hit $370.10 on Friday. With a market capitalization soaring to an impressive $2.75 trillion

3 S&P stocks with growth to weather a downturn: https://www.marketbeat.com/logos/articles/med_20231113071152_3-sp-stocks-with-growth-to-weather-a-downturn.jpg
3 S&P stocks with growth to weather a downturn

If you’re looking for companies with steady profitability, cash flow and dividends, then Broadcom Inc. (NASDAQ: AVGO), McCormick & Co. Inc. (NYSE: MKC) and Merck & Co. (NYSE: MRK) are worthy

3 Dividend Champions with room for dividend growth: https://www.marketbeat.com/logos/articles/med_20231110113832_3-dividend-champions-with-room-for-dividend-growth.jpg
3 Dividend Champions with room for dividend growth

The World Series champion Texas Rangers recently paid nice dividends for sports bettors. For stock investors, there's a different, more predictable group of dividend payers worth betting on — the

Does Logitech earnings signal the end of tech normalization?: https://www.marketbeat.com/logos/articles/med_20231112141258_chart-logi3.jpg
Does Logitech earnings signal the end of tech normalization?

Computer peripherals and accessories manufacturer Logitech International SA  (NASDAQ: LOGI) stock has had a tumultuous ride in 2023. Shareholders were surprised when its decade-long CEO, Bracken

Atlassian fumbles the quarter but is still leading the game: https://www.marketbeat.com/logos/articles/med_20231112141533_chart-team.jpg
Atlassian fumbles the quarter but is still leading the game

Collaboration software developer Atlassian Co. (NASDAQ: TEAM) products enable work teams to operate more effectively. Over 250,000 customers use the company's workflow collaboration and project

Atlassian fumbles the quarter but is still leading the game: https://www.marketbeat.com/logos/articles/med_20231112141533_chart-team.jpg
Atlassian fumbles the quarter but is still leading the game

Collaboration software developer Atlassian Co. (NASDAQ: TEAM) products enable work teams to operate more effectively. Over 250,000 customers use the company's workflow collaboration and project

Arm Holdings fails to pump on earnings but still flexes its IP: https://www.marketbeat.com/logos/articles/med_20231112141838_chart-arm.jpg
Arm Holdings fails to pump on earnings but still flexes its IP

British semiconductor company Arm Holdings plc (NASDAQ: ARM) released its first earnings since reentry into the public markets. While Arm is a semiconductor company in the computer and technology

MAG Silver Reports Third Quarter Financial Results: https://www.irw-press.at/prcom/images/messages/2023/72602/10112023_EN_MAG.003.png
MAG Silver Reports Third Quarter Financial Results

 

Vancouver, B.C. MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) - https://www.commodity-tv.com/ondemand/companies/profil/mag-silver-corp/ - announces the Company’s

MAG Silver meldet Finanzergebnisse für das dritte Quartal : https://www.irw-press.at/prcom/images/messages/2023/72602/10112023_DE_MAG.003.png
MAG Silver meldet Finanzergebnisse für das dritte Quartal

 

Vancouver, B.C. MAG Silver Corp. (TSX / NYSE American: MAG) ("MAG" oder das "Unternehmen") - https://www.commodity-tv.com/ondemand/companies/profil/mag-silver-corp/ - gibt die ungeprüften

Data giants MongoDB and Snowflake just got upgraded: https://www.marketbeat.com/logos/articles/med_20231110091513_these-2-data-giants-just-got-upgraded.jpg
Data giants MongoDB and Snowflake just got upgraded

After a dodgy end to the summer for equities in general, with the benchmark S&P 500 falling finding itself down more than 10% at one point, it's starting to look like Christmas might have come

Will Eli Lilly's Zepbound be the next big weight-loss drug?: https://www.marketbeat.com/logos/articles/med_20231109202516_will-eli-lillys-zepbound-be-the-next-big-weight-lo.jpg
Will Eli Lilly's Zepbound be the next big weight-loss drug?

Eli Lilly & Co. (NYSE: LLY) reversed lower on November 9. This came after LLY stock advanced 3.20% after the company got regulators' OK for its weight-loss drug Zepbound.

In clinical trials, the